Can a fixed dose of donor immune cells make stem cell transplants safer?
NCT ID NCT00959140
First seen Jan 06, 2026 · Last updated May 20, 2026 · Updated 21 times
Summary
This study looks at whether giving a set amount of immune cells (called CD3+ T cells) from a brother or sister donor makes stem cell transplants more predictable and easier to manage. About 20 adults receiving a transplant from a fully matched sibling will get a fixed dose of these cells. The goal is to reduce complications like graft-versus-host disease and improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC STEM CELL TRANSPLANTATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Alabama Hospital
Birmingham, Alabama, 35294, United States
Conditions
Explore the condition pages connected to this study.